secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2026-06-18T20:13:20+00:00
Accession:  0001193125-26-275879
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agios shareholders elect three Class I directors, approve 2M share increase to stock plan
--------------------------------------------------------------------------------

- Elected Rahul Ballal, Brian Goff, and Cynthia Smith as Class I directors for three-year terms expiring 2029.
- Advisory vote on executive compensation approved: 43.4M for, 1.1M against, 1.6M abstain.
- Stockholders approved amendment to 2023 Stock Incentive Plan, increasing authorized shares by 2,000,000.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312526275879/0001193125-26-275879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312526275879/d62491d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-275879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer